Félix Carvalho Selected Research

4-hydroxycyclophosphamide

1/2022

Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Félix Carvalho Research Topics

Disease

22	Hyperthermia 06/2020 - 04/2002
18	Cardiotoxicity 01/2022 - 06/2002
16	Neoplasms (Cancer) 01/2022 - 02/2002
12	Poisoning 01/2019 - 10/2006
9	Inflammation (Inflammations) 11/2021 - 05/2013
9	Necrosis 11/2021 - 06/2010
7	Hypertension (High Blood Pressure) 02/2021 - 02/2002
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2013
6	Pain (Aches) 01/2017 - 05/2013
4	Multiple Sclerosis 01/2022 - 05/2018
4	Fibrosis (Cirrhosis) 11/2021 - 07/2009
3	Renal Insufficiency (Renal Failure) 08/2022 - 12/2015
3	Chemotherapy-Related Cognitive Impairment 01/2022 - 05/2018
3	Gliosis 03/2021 - 01/2016
3	Body Weight (Weight, Body) 01/2021 - 04/2009
3	Weight Loss (Weight Reduction) 01/2020 - 09/2010
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2013
3	Heart Failure 06/2014 - 06/2009
3	Fanconi Anemia (Fanconi's Anemia) 06/2013 - 10/2011
3	Chromosomal Instability (Chromosome Stability) 06/2013 - 10/2011
2	Tachycardia (Tachyarrhythmias) 02/2021 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2010
2	Breast Neoplasms (Breast Cancer) 11/2019 - 04/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2018 - 08/2017
2	Infections 01/2017 - 01/2015
2	Gangrene 01/2017 - 04/2015
2	Thrombophlebitis 01/2017 - 04/2015
2	Jaundice (Icterus) 01/2015 - 08/2010
2	Gout 02/2014 - 02/2002
2	Alcoholism (Alcohol Abuse) 04/2013 - 10/2010
2	Hepatitis 08/2010 - 02/2002
2	Ischemia 06/2009 - 03/2009
2	Reperfusion Injury 03/2009 - 02/2002
2	Hyperplasia 07/2008 - 03/2005
1	Seizures (Absence Seizure) 02/2021
1	Paranoid Disorders (Paranoia) 02/2021

Drug/Important Bio-Agent (IBA)

18	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2020 - 04/2002
16	Pharmaceutical PreparationsIBA 05/2021 - 04/2013
8	ParaquatIBA 06/2015 - 10/2006
7	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2022 - 09/2013
7	Ethanol (Ethyl Alcohol)IBA 01/2018 - 06/2008
7	CatecholaminesIBA 09/2013 - 06/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 05/2018
4	AntioxidantsIBA 11/2021 - 07/2008
4	Synthetic CathinoneIBA 03/2021 - 08/2016
4	Biological ProductsIBA 01/2021 - 03/2012
4	AmphetaminesIBA 01/2020 - 09/2013
4	AntidotesIBA 01/2019 - 07/2008
4	EnzymesIBA 01/2018 - 02/2002
4	Tramadol (K315)FDA LinkGeneric 01/2017 - 11/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2009 - 04/2002
4	Monoamine Oxidase (MAO)IBA 06/2009 - 08/2003
3	RNA Polymerase II (RNA Polymerase B)IBA 08/2022 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2013
3	CannabinoidsIBA 08/2020 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 05/2015
3	AmanitinsIBA 01/2019 - 06/2014
3	Cocaine (Cocaine HCl)IBA 01/2018 - 11/2010
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 07/2017 - 01/2016
3	Opioid Analgesics (Opioids)IBA 01/2017 - 11/2013
3	Tapentadol FDA Link 01/2017 - 01/2016
3	diepoxybutaneIBA 06/2013 - 01/2006
3	HerbicidesIBA 04/2013 - 09/2009
3	Epinephrine (Adrenaline)FDA LinkGeneric 06/2009 - 08/2007
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2008 - 02/2004
3	1,3-dipropyl-8-(4-sulfophenyl)xanthine (PSPX)IBA 07/2008 - 02/2004
2	CytokinesIBA 01/2022 - 09/2014
2	Topoisomerase II InhibitorsIBA 01/2022 - 11/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2010
2	FlavonoidsIBA 01/2021 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 10/2019
2	Glutamic Acid (Glutamate)FDA Link 10/2019 - 06/2009
2	Methylphenidate (Ritalin)FDA LinkGeneric 04/2018 - 08/2017
2	XenobioticsIBA 04/2017 - 05/2011
2	CaspasesIBA 01/2017 - 10/2015
2	desomorphineIBA 01/2017 - 04/2015
2	Piperonyl Butoxide FDA Link 08/2016 - 01/2016
2	cypermethrin (alphamethrin)IBA 08/2016 - 01/2016
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2015 - 10/2006
2	Acetylcysteine (Siran)FDA LinkGeneric 02/2014 - 05/2012
2	Glutathione (Reduced Glutathione)IBA 05/2012 - 08/2011
2	Protective AgentsIBA 05/2012 - 10/2011
2	HepcidinsIBA 06/2010 - 06/2008
2	Serotonin (5 Hydroxytryptamine)IBA 06/2009 - 08/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2009 - 03/2005
2	Mitochondrial DNA (mtDNA)IBA 01/2009 - 09/2007
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Acrolein (Aqualin)IBA 01/2022
1	4-hydroxycyclophosphamideIBA 01/2022
1	ProdrugsIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2021
1	NF-kappa B (NF-kB)IBA 11/2021
1	Effector CaspasesIBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	methyl 2- (1- (4- fluorobenzyl)- 1H- indazole- 3- carboxamido)- 3- methylbutanoateIBA 02/2021

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2014
3	Drug Therapy (Chemotherapy) 01/2022 - 05/2018
2	Surgical Amputation (Amputations) 01/2017 - 04/2015